| cycling time to exhaustion | In one small study of 12 cyclists after mental fatigue, time to exhaustion was longer after a single dose of L-tyrosine 300 mg/kg than after placebo; this high dose is not an established safe training regimen.459.9±199.6 versus 398.7±222.1 s, p=0.008; Hedges g=0.29. Values are given as mean ± SD. | 1/4 Very lowThe study included 12 people, so the result is imprecise. Laboratory exercise after artificial fatigue limits transfer to ordinary training. | 11 trialEffects of L‐Tyrosine Ingestion on Endurance Performance in Mentally Fatigued Cyclists ↗ | 12 male cyclists after a 60-minute Stroop task | - Effects of L‐Tyrosine Ingestion on Endurance Performance in Mentally Fatigued Cyclists ↗
|
|---|
| slope of the increase in perceived exertion | In the same study of 12 cyclists after mental fatigue, perceived exertion during exercise increased more slowly after a single dose of L-tyrosine 300 mg/kg than after placebo.0.560±0.184 versus 0.673±0.251 arbitrary units/min, p=0.03; Hedges g=0.51. Values are given as mean ± SD. | 1/4 Very lowThe study included 12 people, so the result is imprecise. Laboratory exercise after artificial fatigue limits transfer to ordinary training. | 11 trialEffects of L‐Tyrosine Ingestion on Endurance Performance in Mentally Fatigued Cyclists ↗ | 12 male cyclists after a 60-minute Stroop task | - Effects of L‐Tyrosine Ingestion on Endurance Performance in Mentally Fatigued Cyclists ↗
|
|---|
| number of recorded adverse events | In a short study of healthy men, mild or moderate adverse events were recorded with both L-tyrosine 1–4 g/day and placebo; these data do not establish the comparative incidence in people or long-term safety.18 mild or moderate events by period: placebo 4, 1 g 4, 2 g 5, 3 g 1, 4 g 4; overall χ² p=0.04, no dose trend was noted; there were no serious events. | 1/4 Very lowThe study included 30 men and short periods, so rare and late events may have gone unnoticed. The number of events is reported, not the number of people with events; comparative incidence was not established. | 11 trialEvaluation of the Safety and Tolerability of L-Tyrosine Supplementation in Healthy Adult Men: A Randomized Crossover Trial ↗ | 30 healthy men aged 20–60 years were included in the analysis; 24 observations per dose regimen, two withdrew | - Evaluation of the Safety and Tolerability of L-Tyrosine Supplementation in Healthy Adult Men: A Randomized Crossover Trial ↗
|
|---|
| reaction time in the vigilance test | 12 male cyclists after a 60-minute Stroop task: 342.8±58.2 → 394.7±58.9 ms versus 342.6±34.4 → 384.5±44.6 ms; interaction p=0.49. Values are given as mean ± SD. Laboratory exercise after artificially induced mental fatigue; a single weight-based dose is not a daily regimen.342.8±58.2 → 394.7±58.9 ms versus 342.6±34.4 → 384.5±44.6 ms; interaction p=0.49. Values are given as mean ± SD. | 2/4 LowThe result was obtained only in 12 male cyclists after artificially induced mental fatigue. A small beneficial or harmful effect cannot be precisely ruled out; the absence of a significant difference does not mean equality with placebo. | 11 trialEffects of L‐Tyrosine Ingestion on Endurance Performance in Mentally Fatigued Cyclists ↗ | 12 male cyclists after a 60-minute Stroop task | - Effects of L‐Tyrosine Ingestion on Endurance Performance in Mentally Fatigued Cyclists ↗
|
|---|
| anger rating | In one study of service members undergoing simulated captivity and interrogation: Group-by-time interaction for anger p=0.002; at individual time points after interrogations p=0.03 and p<0.001. A model of severe stress is not the same as ordinary stress.Group-by-time interaction for anger p=0.002; at individual time points after interrogations p=0.03 and p<0.001. | 1/4 Very lowThis mood measure was studied in one experiment with service members undergoing simulated captivity and interrogation. Group sizes differ within the article, and the exact difference and its interval for this outcome were not established. | 11 trialThe catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗ | Service members undergoing simulated captivity and interrogation: 36+36 in the abstract, 39+39 in Table 1; the number analyzed for the outcome was not established | - The catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗
|
|---|
| tension | In one study of service members undergoing simulated captivity and interrogation: No significant group-by-time interaction was found; p=0.33. The absence of a significant difference does not prove equality.No significant group-by-time interaction was found; p=0.33. | 1/4 Very lowThis mood measure was studied in one experiment with service members undergoing simulated captivity and interrogation. Group sizes differ within the article, and the exact difference and its interval for this outcome were not established. | 11 trialThe catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗ | Service members undergoing simulated captivity and interrogation: 36+36 in the abstract, 39+39 in Table 1; the number analyzed for the outcome was not established | - The catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗
|
|---|
| Low mood under severe stress (POMS) | No significant group-by-time interaction was found on the POMS low-mood subscale; p=0.48.No significant group-by-time interaction was found; p=0.48. | 1/4 Very lowThis mood measure was studied in one experiment with service members undergoing simulated captivity and interrogation. Group sizes differ within the article, and the exact difference and its interval for this outcome were not established. | 11 trialThe catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗ | Service members undergoing simulated captivity and interrogation: 36+36 in the abstract, 39+39 in Table 1; the number analyzed for the outcome was not established | - The catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗
|
|---|
| vigor | In one study of service members undergoing simulated captivity and interrogation: No significant group-by-time interaction was found; p=0.06. The absence of a significant difference does not prove equality.No significant group-by-time interaction was found; p=0.06. | 1/4 Very lowThis mood measure was studied in one experiment with service members undergoing simulated captivity and interrogation. Group sizes differ within the article, and the exact difference and its interval for this outcome were not established. | 11 trialThe catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗ | Service members undergoing simulated captivity and interrogation: 36+36 in the abstract, 39+39 in Table 1; the number analyzed for the outcome was not established | - The catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗
|
|---|
| fatigue | In one study of service members undergoing simulated captivity and interrogation: No significant group-by-time interaction was found; p=0.35. The absence of a significant difference does not prove equality.No significant group-by-time interaction was found; p=0.35. | 1/4 Very lowThis mood measure was studied in one experiment with service members undergoing simulated captivity and interrogation. Group sizes differ within the article, and the exact difference and its interval for this outcome were not established. | 11 trialThe catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗ | Service members undergoing simulated captivity and interrogation: 36+36 in the abstract, 39+39 in Table 1; the number analyzed for the outcome was not established | - The catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗
|
|---|
| confusion | In one study of service members undergoing simulated captivity and interrogation: No significant group-by-time interaction was found; p=0.64. The absence of a significant difference does not prove equality.No significant group-by-time interaction was found; p=0.64. | 1/4 Very lowThis mood measure was studied in one experiment with service members undergoing simulated captivity and interrogation. Group sizes differ within the article, and the exact difference and its interval for this outcome were not established. | 11 trialThe catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗ | Service members undergoing simulated captivity and interrogation: 36+36 in the abstract, 39+39 in Table 1; the number analyzed for the outcome was not established | - The catecholamine neurotransmitter precursor tyrosine increases anger during exposure to severe psychological stress ↗
|
|---|
| body weight | In a small study of healthy men taking L-tyrosine for four weeks per regimen, no significant differences in body weight from placebo were found. The tolerability study was not a trial of obesity treatment.The authors found no significant differences in body weight compared with placebo; final means for the 0–4 g/day regimens: 71.3±8.6; 70.3±8.4; 70.5±9.2; 70.2±8.3; 69.3±8.3 kg. Values are given as mean ± SD. | 2/4 LowThis is an additional finding from a short tolerability study in healthy men, not a trial of a weight-loss program. The table specifies an analysis of 23 participants; the exact comparative effect and its interval are not provided, so a small effect cannot be ruled out. | 11 trialEvaluation of the Safety and Tolerability of L-Tyrosine Supplementation in Healthy Adult Men: A Randomized Crossover Trial ↗ | 30 healthy men aged 20–60 years; for the Table 3 means, the authors specify n=23, per-protocol analysis | - Evaluation of the Safety and Tolerability of L-Tyrosine Supplementation in Healthy Adult Men: A Randomized Crossover Trial ↗
|
|---|
| assessed diet | In a small study of healthy men taking L-tyrosine for four weeks per regimen, no significant differences in assessed diet from placebo were found. Food intake is not a direct measurement of appetite.No significant differences from placebo were found. Final means ± SD for the 0/1/2/3/4 g/day regimens: energy 1708±480 / 1671±581 / 1666±446 / 1851±445 / 1772±529 kcal/day; protein 61.2±17.5 / 59.4±19.3 / 57.1±16.9 / 62.3±15.4 / 60.6±19.7 g/day; fat 48.8±14.8 / 47.4±16.3 / 45.5±15.2 / 51.3±14.5 / 49.7±15.8 g/day; carbohydrate 239.7±80 / 230.6±93 / 235.6±71 / 260.3±81 / 251.0±91 g/day. | 2/4 LowDiet was assessed using participants’ self-reports, which may not accurately reflect actual intake. This is a short study in healthy men; the absence of a significant difference does not establish an effect on appetite or weight loss. | 11 trialEvaluation of the Safety and Tolerability of L-Tyrosine Supplementation in Healthy Adult Men: A Randomized Crossover Trial ↗ | 30 healthy men aged 20–60 years; for the Table 3 means, the authors specify n=23, per-protocol analysis | - Evaluation of the Safety and Tolerability of L-Tyrosine Supplementation in Healthy Adult Men: A Randomized Crossover Trial ↗
|
|---|